We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEN.B icon
3501
Lennar Class B
LEN.B
$19.4B
$21.1K ﹤0.01%
238
+67
+39% +$5.85K
RFIL icon
3502
RF Industries
RFIL
$89.8M
$21.1K ﹤0.01%
995
+986
+10,956% +$15.9K
LUCD icon
3503
Lucid Diagnostics
LUCD
$158M
$21.1K ﹤0.01%
19,711
+584
+3% +$629
RMAX
3504
DELISTED
RE/MAX Holdings
RMAX
$21.1K ﹤0.01%
2,137
-3,968
-65% -$34.6K
SUNS
3505
Sunrise Realty Trust
SUNS
$97.2M
$21.1K ﹤0.01%
2,665
-480
-15% -$3.86K
LFMD icon
3506
LifeMD
LFMD
$143M
$21K ﹤0.01%
5,096
+2,099
+70% +$9.26K
RELL icon
3507
Richardson Electronics
RELL
$260M
$21K ﹤0.01%
1,107
-1,105
-50% -$17.3K
KROS icon
3508
Keros Therapeutics
KROS
$230M
$21K ﹤0.01%
1,966
-732
-27% -$8.15K
QSI icon
3509
Quantum-Si Incorporated
QSI
$183M
$21K ﹤0.01%
23,758
-1,185
-5% -$1.13K
NCMI icon
3510
National CineMedia
NCMI
$213M
$21K ﹤0.01%
5,526
-5,495
-50% -$18.7K
TILT icon
3511
Northern Trust Morningstar US Market Factor Tilt ETF
TILT
$2.22B
$21K ﹤0.01%
76
-511
-87% -$136K
MDAI icon
3512
Spectral AI
MDAI
$51.2M
$21K ﹤0.01%
+12,121
New +$23.9K
KYTX icon
3513
Kyverna Therapeutics
KYTX
$421M
$21K ﹤0.01%
2,353
-775
-25% -$6.88K
CASS icon
3514
Cass Information Systems
CASS
$693M
$20.9K ﹤0.01%
408
-580
-59% -$27.5K
KRRO icon
3515
Korro Bio
KRRO
$141M
$20.9K ﹤0.01%
1,587
-57
-3% -$708
OCTV
3516
Octave Intelligence
OCTV
$5.05B
$20.9K ﹤0.01%
+1,281
New +$23.5K
BNED icon
3517
Barnes & Noble Education
BNED
$393M
$20.9K ﹤0.01%
1,662
-119
-7% -$1.24K
PHAT icon
3518
Phathom Pharmaceuticals
PHAT
$591M
$20.8K ﹤0.01%
1,917
-24
-1% -$274
MLP icon
3519
Maui Land & Pineapple Co
MLP
$320M
$20.7K ﹤0.01%
1,167
-207
-15% -$3.43K
GIB icon
3520
CGI
GIB
$14B
$20.7K ﹤0.01%
321
-5,468
-94% -$373K
INTT icon
3521
inTEST
INTT
$148M
$20.7K ﹤0.01%
+1,138
New +$19.3K
ELTX icon
3522
Elicio Therapeutics
ELTX
$48.4M
$20.7K ﹤0.01%
5,286
+5,285
+528,500% +$53.1K
MNTK icon
3523
Montauk Renewables
MNTK
$417M
$20.6K ﹤0.01%
13,213
-4,020
-23% -$5.95K
BHR
3524
Braemar Hotels & Resorts
BHR
$116M
$20.6K ﹤0.01%
9,539
-2,872
-23% -$6.88K
LLYVK icon
3525
Liberty Live Group Series C
LLYVK
$9.14B
$20.6K ﹤0.01%
195
-156
-44% -$15.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.